or Try an Advanced Search...

    Overactive Bladder Stocks List

    Symbol Grade Name % Change
    MDT D Medtronic Inc. 0.37
    URGN F UroGen Pharma Ltd. -3.72
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Medicine Ablation Ablation Products Advanced Energy Antineoplastic Drugs Atrial Fibrillation Biologic Product Biologic Products Biopharmaceutical Bladder Cancer Bone Botulinum Toxin Bypass Cancer Carcinoma Cardiac Electrophysiology Catheter Chemotherapy Chronic Pain Cordis

    Related ETFs - A few ETFs which own one or more of the above listed Overactive Bladder stocks.

    Symbol Grade Name Weight
    FLV C American Century Focused Large Cap Value ETF 5.41
    IHI C iShares U.S. Medical Devices ETF 4.86
    ABEQ A Absolute Core Strategy ETF 4.61
    MVAL D SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 4.07
    DIVP B Cullen Enhanced Equity Income ETF 3.99
    View all Overactive Bladder ETFs...
    Compare ETFs
    Compare FLV to DIVP Compare FLV to IHI Compare MVAL to DIVP

        Overactive Bladder Stocks Recent News

        Date Stock Title
        Apr 19 MDT Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity
        Apr 18 MDT Medtronic Stock: Buy, Sell, or Hold?
        Apr 17 URGN UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
        Apr 17 MDT Americans favor quality over quantity in pursuit of longevity
        Apr 17 MDT The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic
        Apr 16 MDT Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
        Apr 16 MDT Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola
        Apr 16 MDT 2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
        Apr 15 URGN UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
        Apr 15 MDT Edwards pushes back on Medtronic’s head-to-head TAVR trial
        Apr 14 URGN UroGen Pharma Ltd.'s (NASDAQ:URGN) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week
        Apr 13 MDT Medtronic: Dividend Aristocrat Value In Plain Sight
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Medicine Ablation Ablation Products Advanced Energy Antineoplastic Drugs Atrial Fibrillation Biologic Product Biologic Products Biopharmaceutical Bladder Cancer Bone Botulinum Toxin Bypass Cancer Carcinoma Cardiac Electrophysiology Catheter Chemotherapy Chronic Pain Cordis
        Overactive Bladder

        Overactive bladder (OAB) is a condition in which the bladder muscles contract uncontrollably, causing a sudden and frequent urge to urinate. People with OAB may also experience urinary incontinence, or the inability to control the release of urine. OAB is a common condition that affects millions of people worldwide. Treatment options include lifestyle changes, medications, and in some cases, surgery.

        Browse All Tags